Interested parties can access the live presentation through the company’s investor relations portal at investor.viatris.com. For those preferring telephone access, the firm has provided dedicated lines at 844-308-3344 for domestic participants and 412-317-1896 for international callers. A recorded version of the session will remain available on the company website following the event. The announcement marks the latest update from the global healthcare provider, which maintains a broad portfolio spanning generics, established brands, and value-added medicines across its primary hubs in the United States, China, and India.